Search All News
The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
- January 4, 2022
Babies born during the pandemic’s first year—even to moms who did not have COVID during pregnancy—scored slightly lower on a screening test of social and motor skills compared to pre-pandemic babies.
- December 17, 2021
A new study from COVID researchers at Columbia and the University of Hong Kong adds more evidence that the omicron variant can evade the immune protection conferred by vaccines and natural infection.
- November 24, 2021
New Columbia studies quantify the effect of the COVID pandemic on health care workers' sleep patterns and the potential damaging consequences of sleep disturbance on their mental health.
- November 22, 2021
After nearly dying from COVID-19 last year, the world-renowned transplant surgeon reflects on his recovery and completing his eighth New York City Marathon.
- November 17, 2021
Now in its fifth year, the center has built close relationships with members of the Harlem and Washington Heights communities. Those relationships were pivotal when COVID-19 arrived.